Methods for the Detection of Peptidylarginine Deiminase (PAD) Activity and Protein Citrullination*

The post-translational conversion of peptidylarginine to peptidylcitrulline, a process also known as citrullination, is catalyzed by the enzyme family of peptidylarginine deiminases (PADs) and has been demonstrated to be involved in many physiological processes, including the regulation of gene expression. In addition, citrullination has been shown to be associated with several diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and Alzheimer's disease. To get more insight into the role of PAD enzymes and citrullination in both health and disease, experimental strategies to study PAD activity and to characterize citrullinated proteins in complex biological samples are crucial. Here, we describe the chemical, proteomic and antibody-based procedures that are currently available and discuss their applicability for the analysis of complex samples. The methods that have been developed can be used to provide more insight in the substrate specificity of PAD enzymes. Because the evidence that PADs play a pathophysiological role in the diseases mentioned above is increasing, they become attractive targets for therapeutic interventions. More knowledge of PAD specificity and the availability of reliable, high-throughput assays for PAD activity will facilitate the development of highly specific PAD inhibitors.

[1]  T. Senshu,et al.  Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. , 1992, Analytical biochemistry.

[2]  P. Proost,et al.  Detection and Quantification of Citrullinated Chemokines , 2011, PloS one.

[3]  G. Pruijn,et al.  The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and β-actin. , 2013, Arthritis and rheumatism.

[4]  B. Fleckenstein,et al.  Targeted analysis of protein citrullination using chemical modification and tandem mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[5]  D. Lawrence,et al.  Monitoring of protein arginine deiminase activity by using fluorescence quenching: multicolor visualization of citrullination. , 2013, Angewandte Chemie.

[6]  M. Radic,et al.  Histone Deimination As a Response to Inflammatory Stimuli in Neutrophils1 , 2008, The Journal of Immunology.

[7]  D. Deforce,et al.  Modification of citrulline residues with 2,3-butanedione facilitates their detection by liquid chromatography/mass spectrometry. , 2011, Rapid communications in mass spectrometry : RCM.

[8]  G. Pruijn,et al.  Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients , 2012, Arthritis Research & Therapy.

[9]  P. Thompson,et al.  Chemical and biological methods to detect post‐translational modifications of arginine , 2014, Biopolymers.

[10]  T. Kato,et al.  A highly sensitive high-performance liquid chromatography-- fluorometric method for the assay of peptidylarginine deiminase activity. , 2000, Analytical biochemistry.

[11]  Toshiyuki Shimizu,et al.  Structural basis for Ca2+-induced activation of human PAD4 , 2004, Nature Structural &Molecular Biology.

[12]  Felipe Andrade,et al.  Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis , 2011, Annals of the rheumatic diseases.

[13]  G. Pruijn,et al.  ABAP: antibody-based assay for peptidylarginine deiminase activity. , 2007, Analytical biochemistry.

[14]  L. Klareskog,et al.  Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells , 2008, Annals of the rheumatic diseases.

[15]  J. Knappe,et al.  Modified determination of citrulline. , 1968, Analytical biochemistry.

[16]  C. Ackerley,et al.  Myelin in multiple sclerosis is developmentally immature. , 1994, The Journal of clinical investigation.

[17]  R. Wait,et al.  Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. , 2008, Arthritis and rheumatism.

[18]  Sangwon Cha,et al.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of peptide citrullination site using Br signature. , 2013, Analytical biochemistry.

[19]  E. Vossenaar,et al.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  M. Knipp,et al.  A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline. , 2000, Analytical biochemistry.

[21]  L. Sollid,et al.  Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4 , 2009, Biological chemistry.

[22]  L. Sollid,et al.  Specific modification of peptide-bound citrulline residues. , 2006, Analytical biochemistry.

[23]  Yanming Wang,et al.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. , 2013, Biochimica et biophysica acta.

[24]  L. Martens,et al.  Getting intimate with trypsin, the leading protease in proteomics. , 2013, Mass spectrometry reviews.

[25]  A. Nicholas,et al.  Preparation of a monoclonal antibody to citrullinated epitopes: Its characterization and some applications to immunohistochemistry in human brain , 2002, Glia.

[26]  Annette Lee,et al.  Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis , 2008, Arthritis research & therapy.

[27]  B. Fleckenstein,et al.  Specific biotinylation and sensitive enrichment of citrullinated peptides , 2013, Analytical and Bioanalytical Chemistry.

[28]  F. Mastronardi,et al.  Peptidylarginine deiminase: a candidate factor in demyelinating disease , 2002, Journal of neurochemistry.

[29]  M. Sebbag,et al.  Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. , 2007, Arthritis and rheumatism.

[30]  G. Pruijn,et al.  Anti-CCP antibodies: the past, the present and the future , 2011, Nature Reviews Rheumatology.

[31]  D. Baeten,et al.  Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. , 2005, Arthritis and rheumatism.

[32]  G. Pruijn,et al.  Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis , 2012, Arthritis Research & Therapy.

[33]  A. Chumanevich,et al.  Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination. , 2012, Journal of the American Chemical Society.

[34]  Jennifer E Van Eyk,et al.  Identification and characterization of citrulline‐modified brain proteins by combining HCD and CID fragmentation , 2013, Proteomics.

[35]  W. V. van Venrooij,et al.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages , 2004, Annals of the rheumatic diseases.

[36]  F. Koushesh,et al.  Modified methods for measuring citrulline and carbamoyl-beta-alanine with reduced light sensitivity and sucrose interference. , 1987, Analytical biochemistry.

[37]  A. Suzuki,et al.  Comparison of enzymatic properties between hPADI2 and hPADI4. , 2005, Biochemical and biophysical research communications.

[38]  S. Grisolía,et al.  A sensitive and convenient micromethod for estimation of urea, citrulline, and carbamyl derivatives. , 1966, Analytical biochemistry.

[39]  W. V. van Venrooij,et al.  Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. , 2003, The Journal of rheumatology.

[40]  S. Gross,et al.  Neutral loss of isocyanic acid in peptide CID spectra: A novel diagnostic marker for mass spectrometric identification of protein citrullination , 2009, Journal of the American Society for Mass Spectrometry.

[41]  Yuejian Wang,et al.  Screening Citrullinated Proteins in Synovial Tissues of Rheumatoid Arthritis Using 2-dimensional Western Blotting , 2013, The Journal of Rheumatology.

[42]  M. M. Pires,et al.  Facile Fluorescence‐Based Detection of PAD4‐Mediated Citrullination , 2013, Chembiochem : a European journal of chemical biology.

[43]  R. Archibald.  DETERMINATION OF CITRULLINE AND ALLANTOIN AND DEMONSTRATION OF CITRULLINE IN BLOOD PLASMA , 1944 .

[44]  C. Allis,et al.  Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation , 2009, The Journal of cell biology.

[45]  R. Schasfoort,et al.  Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance , 2010, Arthritis research & therapy.

[46]  K. Ichikawa,et al.  Determination of sites citrullinated by peptidylarginine deiminase using 18O stable isotope labeling and mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[47]  W. Fearon.  The carbamido diacetyl reaction: a test for citrulline. , 1939, The Biochemical journal.

[48]  S. Mohammed,et al.  Automated Online Sequential Isotope Labeling for Protein Quantitation Applied to Proteasome Tissue-specific Diversity*S , 2008, Molecular & Cellular Proteomics.

[49]  H. Cooper,et al.  On-line liquid chromatography neutral loss-triggered electron transfer dissociationmass spectrometry for the targeted analysis of citrullinated peptides. , 2011, Analytical methods : advancing methods and applications.

[50]  Guang-Yaw Liu,et al.  A continuous spectrophotometric assay method for peptidylarginine deiminase type 4 activity. , 2005, Analytical biochemistry.

[51]  Johan Lengqvist,et al.  MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen , 2010, Proteomics. Clinical applications.

[52]  Patricia Stadtmüller,et al.  A technique for the specific enrichment of citrulline-containing peptides. , 2010, Analytical biochemistry.

[53]  G. Pruijn,et al.  Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice. , 2013, Biochimie.

[54]  M. Rahmatullah,et al.  Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. , 1980, Analytical biochemistry.

[55]  Mariana J. Kaplan,et al.  Neutrophils in the pathogenesis and manifestations of SLE , 2011, Nature Reviews Rheumatology.

[56]  Michael R. Lindberg,et al.  PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps , 2010, The Journal of experimental medicine.

[57]  A. Kawada,et al.  Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. , 2001, European journal of biochemistry.